Disseminated vegetating infantile bromoderma: A dramatic response to systemic steroids

Bromoderma is a rare hypersensitivity reaction caused by bromide intake. It was relatively frequent in the early years of the previous century because of the common use of bromide‐containing solutions in pediatrics due to their antispasmodic, expectorant, sedative, and anticonvulsant effects. Although recently prohibited in many countries, bromides are still used as an adjuvant anticonvulsant drug and still present in some over the counter antispasmodics and analgesics. Bromoderma usually present with pustular and vegetating lesions that may represent a diagnostic challenge for dermatologists. We describe a severe case of vegetating bromoderma that showed an excellent response to the withdrawal of the bromide‐containing medication associated with systemic steroid administration.

[1]  S. Knake,et al.  Diffuse vegetating bromoderma , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  M. Jinnin,et al.  Bromoderma in a pituitary adenoma patient treated with bromocriptine , 2017, The Journal of dermatology.

[3]  A. Kiszewski,et al.  Bromoderma in an infant* , 2016, Anais brasileiros de dermatologia.

[4]  K. Sayama,et al.  Bromoderma mimicking pyoderma gangrenosum caused by commercial sedatives , 2016, The Journal of dermatology.

[5]  J. Kaczmarczyk,et al.  Infantile bromoderma due to antiepileptic therapy , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[6]  S. Nabatame,et al.  Bromoderma in a patient with migrating partial seizures in infancy , 2010, Epilepsy Research.

[7]  M. Musolino,et al.  Single-plaque vegetating bromoderma. , 2008, Journal of the American Academy of Dermatology.

[8]  J. Hafiji,et al.  A case of bromoderma and bromism , 2007, The British journal of dermatology.

[9]  A. Castells,et al.  Vegetant Bromoderma in an Infant , 2001, Pediatric dermatology.